Related Experiment Video
Updated: Jun 20, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Programmable mycolysins expand the antimicrobial toolkit against mycobacteria
Carlos São-José1, Madalena Pimentel1
1Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisboa, Portugal.
None:
In a timely advance for antimycobacterial biotechnology, Abouhmad et al. engineered modular 'mycolysins' that combine mycobacteriophage lysis functions with membrane-active peptides to efficiently breach the mycobacterial envelope and achieve pathogen intracellular killing. Their work opens a route that may accelerate the development of biologics against tuberculosis and nontuberculous mycobacterial diseases.
Related Concept Videos
Antifungal Agents
Chemical Agents for Microbial Control
Antimicrobial Effectiveness
iChip
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance

